Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |